308 related articles for article (PubMed ID: 21505340)
1. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
Venick RS; Calkins K
Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 lipids for intestinal failure associated liver disease.
Diamond IR; Pencharz PB; Wales PW
Semin Pediatr Surg; 2009 Nov; 18(4):239-45. PubMed ID: 19782305
[TBL] [Abstract][Full Text] [Related]
3. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
[TBL] [Abstract][Full Text] [Related]
4. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
de Meijer VE; Gura KM; Le HD; Meisel JA; Puder M
JPEN J Parenter Enteral Nutr; 2009; 33(5):541-7. PubMed ID: 19571170
[TBL] [Abstract][Full Text] [Related]
5. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
[TBL] [Abstract][Full Text] [Related]
6. The use of Omegaven in treating parenteral nutrition-associated liver disease.
Park KT; Nespor C; Kerner J
J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.
Rochling FA
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801970
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
9. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
Fallon EM; Le HD; Puder M
Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
[TBL] [Abstract][Full Text] [Related]
10. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
11. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?
Diamond IR; Pencharz PB; Wales PW
Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570
[TBL] [Abstract][Full Text] [Related]
12. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
Koletzko B; Goulet O
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):321-6. PubMed ID: 20393276
[TBL] [Abstract][Full Text] [Related]
13. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
Cober MP; Teitelbaum DH
Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
[TBL] [Abstract][Full Text] [Related]
14. Fish oil emulsions in the management of intestinal failure-associated liver disease.
Mercer DF
J Clin Gastroenterol; 2012; 46(10):823-7. PubMed ID: 23060217
[TBL] [Abstract][Full Text] [Related]
15. Some new insights in intestinal failure-associated liver disease.
Goulet O; Joly F; Corriol O; Colomb-Jung V
Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
[TBL] [Abstract][Full Text] [Related]
16. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the management of intestinal failure-associated liver disease.
Wiles A; Woodward JM
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):265-72. PubMed ID: 19339882
[TBL] [Abstract][Full Text] [Related]
18. Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome.
Gura KM; Puder M
Nutr Clin Pract; 2010 Aug; 25(4):399-402. PubMed ID: 20702846
[TBL] [Abstract][Full Text] [Related]
19. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure.
Soden JS; Lovell MA; Brown K; Partrick DA; Sokol RJ
J Pediatr; 2010 Feb; 156(2):327-31. PubMed ID: 20105644
[TBL] [Abstract][Full Text] [Related]
20. Intravenous Fish Oil and Serum Fatty Acid Profiles in Pediatric Patients With Intestinal Failure-Associated Liver Disease.
Ong ML; Venick RS; Shew SB; Dunn JCY; Reyen L; Grogan T; Calkins KL
JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):717-725. PubMed ID: 30900274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
